Literature DB >> 27014426

Characteristic endoscopic findings and risk factors for cytomegalovirus-associated colitis in patients with active ulcerative colitis.

Yutaka Hirayama1, Takafumi Ando1, Yoshiki Hirooka1, Osamu Watanabe1, Ryoji Miyahara1, Masanao Nakamura1, Takeshi Yamamura1, Hidemi Goto1.   

Abstract

AIM: To identify characteristic endoscopic findings and risk factors for cytomegalovirus (CMV)-associated colitis in patients with active ulcerative colitis (UC).
METHODS: A total of 149 UC patients admitted to the Department of Gastroenterology, Nagoya University Hospital, from January 2004 to December 2013 with exacerbation of UC symptoms were enrolled in this retrospective study. All medical records, including colonoscopy results, were reviewed. CMV infection was determined by the presence of CMV antigen, CMV inclusion bodies in biopsy specimens, or positive specific immunohistochemical staining for CMV. Multivariate analysis was used to identify independent risk factors for CMV colitis.
RESULTS: Multivariate analysis indicated independent associations with the extent of disease (pancolitis) and use of > 400 mg corticosteroids for the previous 4 wk. In contrast, no association was seen with sex, age at UC diagnosis, immunomodulator use, or infliximab use. Punched-out ulceration was also significantly associated with CMV infection in patients with active UC (odds ratio = 12.672, 95%CI: 4.210-38.143).
CONCLUSION: Identification of a total corticosteroid dose > 400 mg for 4 wk, extensive colitis and a specific endoscopic finding of punched-out ulcer might facilitate the more rapid diagnosis and timely initiation of antiviral therapy for CMV-associated colitis in patients with active UC.

Entities:  

Keywords:  Antigenemia; Colonoscopy; Cytomegalovirus; Risk factor; Ulcerative colitis

Year:  2016        PMID: 27014426      PMCID: PMC4804188          DOI: 10.4253/wjge.v8.i6.301

Source DB:  PubMed          Journal:  World J Gastrointest Endosc


  45 in total

Review 1.  Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander?

Authors:  Garrett Lawlor; Alan C Moss
Journal:  Inflamm Bowel Dis       Date:  2010-09       Impact factor: 5.325

2.  Definition and diagnosis of cytomegalovirus colitis in patients infected by human immunodeficiency virus.

Authors:  L Beaugerie; C Cywiner-Golenzer; L Monfort; P M Girard; F Carbonnel; Y Ngô; J Cosnes; W Rozenbaum; J C Nicolas; F P Châtelet; J P Gendre
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-04-15

3.  Diagnostic value of antigenemia assay for cytomegalovirus gastrointestinal disease in immunocompromised patients.

Authors:  Naoyoshi Nagata; Masao Kobayakawa; Takuro Shimbo; Kazufusa Hoshimoto; Tomoyuki Yada; Takuji Gotoda; Junichi Akiyama; Shinichi Oka; Naomi Uemura
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

4.  Outcome of cytomegalovirus infections in patients with inflammatory bowel disease.

Authors:  K A Papadakis; J K Tung; S W Binder; L Y Kam; M T Abreu; S R Targan; E A Vasiliauskas
Journal:  Am J Gastroenterol       Date:  2001-07       Impact factor: 10.864

5.  Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis.

Authors:  Xavier Roblin; Sylvie Pillet; Abderrahim Oussalah; Philippe Berthelot; Emilie Del Tedesco; Jean-Marc Phelip; Marie-Laure Chambonnière; Olivier Garraud; Laurent Peyrin-Biroulet; Bruno Pozzetto
Journal:  Am J Gastroenterol       Date:  2011-07-26       Impact factor: 10.864

6.  Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis.

Authors:  M Cottone; G Pietrosi; G Martorana; A Casà; G Pecoraro; L Oliva; A Orlando; M Rosselli; A Rizzo; L Pagliaro
Journal:  Am J Gastroenterol       Date:  2001-03       Impact factor: 10.864

7.  Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies.

Authors:  Takuya Yoshino; Hiroshi Nakase; Satoru Ueno; Norimitsu Uza; Satoko Inoue; Sakae Mikami; Minoru Matsuura; Katsuyuki Ohmori; Takaki Sakurai; Satoshi Nagayama; Suguru Hasegawa; Yoshiharu Sakai; Tsutomu Chiba
Journal:  Inflamm Bowel Dis       Date:  2007-12       Impact factor: 5.325

8.  Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study.

Authors:  Neeraja Kambham; Rohini Vij; Christine A Cartwright; Teri Longacre
Journal:  Am J Surg Pathol       Date:  2004-03       Impact factor: 6.394

Review 9.  Gastrointestinal cytomegalovirus disease.

Authors:  R W Goodgame
Journal:  Ann Intern Med       Date:  1993-11-01       Impact factor: 25.391

10.  Cytomegalovirus infection of the colon: a possible role in exacerbations of inflammatory bowel disease.

Authors:  T Berk; S J Gordon; H Y Choi; H S Cooper
Journal:  Am J Gastroenterol       Date:  1985-05       Impact factor: 10.864

View more
  8 in total

Review 1.  CMV Infection in Pediatric IBD.

Authors:  Anat Yerushalmy-Feler; Sharona Kern-Isaacs; Shlomi Cohen
Journal:  Curr Gastroenterol Rep       Date:  2018-03-28

2.  Clinical characteristics of cytomegalovirus colitis: a 15-year experience from a tertiary reference center.

Authors:  Puo-Hsien Le; Wey-Ran Lin; Chia-Jung Kuo; Ren-Chin Wu; Jun-Te Hsu; Ming-Yao Su; Chun-Jung Lin; Cheng-Tang Chiu
Journal:  Ther Clin Risk Manag       Date:  2017-12-15       Impact factor: 2.423

3.  Pancolitis associated with higher mortality risk of cytomegalovirus colitis in patients without inflammatory bowel disease.

Authors:  Puo-Hsien Le; Chia-Jung Kuo; Ren-Chin Wu; Jun-Te Hsu; Ming-Yao Su; Chun-Jung Lin; Cheng-Tang Chiu
Journal:  Ther Clin Risk Manag       Date:  2018-08-20       Impact factor: 2.423

4.  Cytomegalovirus colitis in inflammatory bowel disease and after haematopoietic stem cell transplantation: diagnostic accuracy, predictors, risk factors and disease outcome.

Authors:  Eirini Mavropoulou; Kristin Ternes; Nicolae-Catalin Mechie; Sebastian Christopher Benjamin Bremer; Steffen Kunsch; Volker Ellenrieder; Albrecht Neesse; Ahmad Amanzada
Journal:  BMJ Open Gastroenterol       Date:  2019-02-27

5.  Cytomegalovirus enterocolitis with subsequent diagnosis of coexisting new-onset inflammatory bowel disease: Two case reports and review of the literature.

Authors:  Panupong Luangsirithanya; Sukrit Treewaree; Ananya Pongpaibul; Nonthalee Pausawasdi; Julajak Limsrivilai
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

6.  Clinical Features, Endoscopic Findings, and Predictive Factors for Mortality in Tissue-Invasive Gastrointestinal Cytomegalovirus Disease between Immunocompetent and Immunocompromised Patients.

Authors:  Panu Wetwittayakhlang; Natthapat Rujeerapaiboon; Poowadon Wetwittayakhlung; Pimsiri Sripongpun; Nannapat Pruphetkaew; Sawangpong Jandee; Naichaya Chamroonkul; Teerha Piratvisuth
Journal:  Gastroenterol Res Pract       Date:  2021-04-06       Impact factor: 2.260

Review 7.  Current Diagnostic and Therapeutic Approaches to Cytomegalovirus Infections in Ulcerative Colitis Patients Based on Clinical and Basic Research Data.

Authors:  Yoshihiro Yokoyama; Tsukasa Yamakawa; Takehiro Hirano; Tomoe Kazama; Daisuke Hirayama; Kohei Wagatsuma; Hiroshi Nakase
Journal:  Int J Mol Sci       Date:  2020-03-31       Impact factor: 5.923

Review 8.  Acute abdomen in the immunocompromised patient: WSES, SIS-E, WSIS, AAST, and GAIS guidelines.

Authors:  Federico Coccolini; Mario Improta; Massimo Sartelli; Kemal Rasa; Robert Sawyer; Raul Coimbra; Massimo Chiarugi; Andrey Litvin; Timothy Hardcastle; Francesco Forfori; Jean-Louis Vincent; Andreas Hecker; Richard Ten Broek; Luigi Bonavina; Mircea Chirica; Ugo Boggi; Emmanuil Pikoulis; Salomone Di Saverio; Philippe Montravers; Goran Augustin; Dario Tartaglia; Enrico Cicuttin; Camilla Cremonini; Bruno Viaggi; Belinda De Simone; Manu Malbrain; Vishal G Shelat; Paola Fugazzola; Luca Ansaloni; Arda Isik; Ines Rubio; Itani Kamal; Francesco Corradi; Antonio Tarasconi; Stefano Gitto; Mauro Podda; Anastasia Pikoulis; Ari Leppaniemi; Marco Ceresoli; Oreste Romeo; Ernest E Moore; Zaza Demetrashvili; Walter L Biffl; Imitiaz Wani; Matti Tolonen; Therese Duane; Sameer Dhingra; Nicola DeAngelis; Edward Tan; Fikri Abu-Zidan; Carlos Ordonez; Yunfeng Cui; Francesco Labricciosa; Gennaro Perrone; Francesco Di Marzo; Andrew Peitzman; Boris Sakakushev; Michael Sugrue; Marja Boermeester; Ramiro Manzano Nunez; Carlos Augusto Gomes; Miklosh Bala; Yoram Kluger; Fausto Catena
Journal:  World J Emerg Surg       Date:  2021-08-09       Impact factor: 5.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.